AIM
ENZ

Acrospire Investment Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Acrospire Investment Management’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-6,214
Closed -$69K – 1506
2017
Q2 		$69K Sell
6,214
-3,042
-33% -$28.3K 0.06% 548
2017
Q1 		$77K Sell
9,256
-36,964
-80% -$260K 0.06% 521
2016
Q4 		$321K Sell
46,220
-9,224
-17% -$58.9K 0.13% 128
2016
Q3 		$282K Buy
55,444
+18,502
+50% +$110K 0.19% 26
2016
Q2 		$221K Sell
36,942
-23,164
-39% -$129K 0.16% 40
2016
Q1 		$273K Buy
+60,106
New +$268K 0.19% 88

Other funds holding ENZ

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acrospire Investment Management's ENZ Position: Q3 2017 in Review

Acrospire Investment Management sold out of Enzo Biochem, Inc. (ENZ) in Q3 2017, closing a stake of 6,214 shares — an estimated $69K sold.

Acrospire Investment Management first reported a position in ENZ in Q1 2016 and held it in 6 quarters. The position peaked at $321K in Q4 2016. 116 funds tracked by Wall St. Rank hold ENZ as of Q3 2017.

  • Acrospire Investment Management reported no remaining Enzo Biochem, Inc. position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 6,214 Enzo Biochem, Inc. shares in Q3 2017, an estimated $69K.
  • Acrospire Investment Management first reported a position in Enzo Biochem, Inc. in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's Enzo Biochem, Inc. position peaked at $321K in Q4 2016.
  • 116 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.